Form 4: Takeda Pharmaceutical Co CEO Sells Shares
Insider Transaction (Form 4)
Julie So-Young Kim, President and CEO and a Director of Takeda Pharmaceutical Co Ltd, sold 89,090 shares of common stock on August 10, 2026 for $17.10 per share.
Summary
- Open-market sale: disposed of 89,090 American Depositary Shares at $17.10 ($1,523,439) on August 10, 2026; holds 391,489 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,523,439 of stock on the open market.
Insider Transactions
Julie So-Young Kim — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | American Depositary Shares | 89,090 | $17 | $1.5M | 391,489 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (89,090 shares) |
Keywords
insider transaction, Form 4, TAK, TAKEDA PHARMACEUTICAL CO LTD, bearish, Julie So-Young Kim
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.